American College of Obstetricians and Gynecologists
ACOG Clinical Practice Update: Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation
Abstract
This Clinical Practice Update provides revised guidance on Rh testing and Rh D immune globulin administration for individuals undergoing abortion or experiencing pregnancy loss at less than 12 0/7 weeks of gestation. This document updates Practice Bulletin No. 225, Medication Abortion Up to 70 Days of Gestation (Obstet Gynecol 2020;136:e31-47); Practice Bulletin No. 200, Early Pregnancy Loss (Obstet Gynecol 2018;132:e197-207); and Practice Bulletin No. 181, Prevention of Rh D Alloimmunization (Obstet Gynecol 2017;130:e57-70).
Source and rights
Published by Obstetrics and gynecology, 2024. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- American College of Obstetricians and Gynecologists
- Published
- 2024
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- Obstetrics and gynecology
- PubMed
- 39255498
- Added to Prognia
- 22 July 2026
More in obstetrics and gynaecology
- Expert opinion by the Italian Society of Gynecology of the Third Age (SIGiTE) and the Italian Society of Menopause (SIM) on diagnosis and treatment of premature ovarian insufficiencyEuropean Respiratory Society · 2026
- Preexisting diabetes: Expert consensus from the College of French Gynecologists and Obstetricians and from the French Society of DiabetologyCollege of French Gynecologists and Obstetricians and French Society of Diabetology · 2026
